Predicting HIV-1 coreceptor usage with sequence analysis - PubMed (original) (raw)
Review
. 2003 Apr-Jun;5(2):104-12.
Affiliations
- PMID: 12876899
Review
Predicting HIV-1 coreceptor usage with sequence analysis
Mark A Jensen et al. AIDS Rev. 2003 Apr-Jun.
Abstract
Bioinformatics approaches are increasingly being used to identify and understand the genetic variation underlying changes in HIV-1 biological phenotype. The variable regions of the viral envelope are the major determinant of virus coreceptor usage and cell tropism. Specifically, amino acids 11 and 25 in the 3rd variable (V3) loop have been found to strongly influence viral syncytium inducing capacity and coreceptor usage. Many additional V3 loop changes, however, as well as changes elsewhere in Env, are thought to contribute to phenotype. In this review we describe several recently developed methods to analyze this variability and their use to predict biological phenotype based on sequence information. These approaches have identified changes in the V3 loop, in addition to the known changes at positions 11 and 25, that affect phenotype and significantly enhance our ability to predict phenotype from genotype. Besides improving phenotype prediction, methods that score V3 sequences on a continuous scale can also assist in the interpretation of evolutionary information about shifts in phenotype, and the relationship between that evolution and pathogenesis. Several examples and potential practical applications of this scoring are discussed. We conclude that advances in computational approaches have enhanced both our ability to predict and to understand HIV-1 biological phenotype evolution. Further development of these methods, by extending analysis to regions outside the V3 loop and to clades beyond subtype B, will extend our understanding of HIV-1 pathogenesis and inform treatment strategies.
Similar articles
- [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
Hei FX, Hong KX, Song YH, Tang HL, Peng H, Xu JQ, Xing H, Shao YM. Hei FX, et al. Zhonghua Yi Xue Za Zhi. 2004 Dec 2;84(23):1968-72. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15730807 Chinese. - Genotypic coreceptor analysis.
Sierra S, Kaiser R, Thielen A, Lengauer T. Sierra S, et al. Eur J Med Res. 2007 Oct 15;12(9):453-62. Eur J Med Res. 2007. PMID: 17933727 Review. - HIV coreceptor phenotyping in the clinical setting.
Low AJ, Swenson LC, Harrigan PR. Low AJ, et al. AIDS Rev. 2008 Jul-Sep;10(3):143-51. AIDS Rev. 2008. PMID: 18820716 Review.
Cited by
- Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy.
Ouyang Y, Yin Q, Li W, Li Z, Kong D, Wu Y, Hong K, Xing H, Shao Y, Jiang S, Ying T, Ma L. Ouyang Y, et al. Sci Rep. 2017 Jul 24;7(1):6222. doi: 10.1038/s41598-017-05594-5. Sci Rep. 2017. PMID: 28740221 Free PMC article. - Evolution of coreceptor utilization to escape CCR5 antagonist therapy.
Zhang J, Gao X, Martin J, Rosa B, Chen Z, Mitreva M, Henrich T, Kuritzkes D, Ratner L. Zhang J, et al. Virology. 2016 Jul;494:198-214. doi: 10.1016/j.virol.2016.04.010. Epub 2016 Apr 26. Virology. 2016. PMID: 27128349 Free PMC article. - Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies.
Kufareva I, Salanga CL, Handel TM. Kufareva I, et al. Immunol Cell Biol. 2015 Apr;93(4):372-83. doi: 10.1038/icb.2015.15. Epub 2015 Feb 24. Immunol Cell Biol. 2015. PMID: 25708536 Free PMC article. Review. - Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients.
Ceresola ER, Nozza S, Sampaolo M, Pignataro AR, Saita D, Ferrarese R, Ripa M, Deng W, Mullins JI, Boeri E, Tambussi G, Toniolo A, Lazzarin A, Clementi M, Canducci F. Ceresola ER, et al. J Antimicrob Chemother. 2015 May;70(5):1391-5. doi: 10.1093/jac/dku573. Epub 2015 Jan 20. J Antimicrob Chemother. 2015. PMID: 25608585 Free PMC article. - Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences.
Aiamkitsumrit B, Dampier W, Martin-Garcia J, Nonnemacher MR, Pirrone V, Ivanova T, Zhong W, Kilareski E, Aldigun H, Frantz B, Rimbey M, Wojno A, Passic S, Williams JW, Shah S, Blakey B, Parikh N, Jacobson JM, Moldover B, Wigdahl B. Aiamkitsumrit B, et al. PLoS One. 2014 Sep 29;9(9):e107389. doi: 10.1371/journal.pone.0107389. eCollection 2014. PLoS One. 2014. PMID: 25265194 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- AI0714/AI/NIAID NIH HHS/United States
- AI37984/AI/NIAID NIH HHS/United States
- AI52028/AI/NIAID NIH HHS/United States
- HG002360/HG/NHGRI NIH HHS/United States
- HL072631/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Other Literature Sources